Atuveciclib,也被称为BAY1143572,是一种具有高度选择性、有效和口服的PTEFb/CDK9抑制剂,目前处于第一阶段。
For research use only. We do not sell to patients.
Name | BAY1143572 |
---|---|
Iupac Chemical Name | (3-((4-(4-fluoro-2-methoxyphenyl)-1,3,5-triazin-2-yl)amino)benzyl)(imino)(methyl)-l6-sulfanone |
Synonyms | BAY1143572; BAY 1143572; BAY-1143572;Atuveciclib. |
Molecular Formula | C18H18FN5O2S |
Molecular Weight | 387.4334 |
Smile | O=S(C)(CC1=CC=CC(NC2=NC(C3=CC=C(F)C=C3OC)=NC=N2)=C1)=N |
InChiKey | ACWKGTGIJRCOOM-UHFFFAOYSA-N |
InChi | InChI=1S/C18H18FN5O2S/c1-26-16-9-13(19)6-7-15(16)17-21-11-22-18(24-17)23-14-5-3-4-12(8-14)10-27(2,20)25/h3-9,11,20H,10H2,1-2H3,(H,21,22,23,24) |
CAS Number | 1414943-88-6 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | 类白色至白色固体 |
---|---|
Purity | >98% |
Storage | 短期可在0-4度保存,数天至数月;长期可在-20度保存三年。 |
Solubility | 可溶于DMSO |
Handling | |
Shipping Condition | 可在常温下运输 |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |